Bio-Process Systems Alliance Responds to European Chemicals Agency's Proposed Universal Ban on PFAS
PFAS are used extensively across multiple industries, including bioprocessing, due to their unique functional properties and low reactivity.
- PFAS are used extensively across multiple industries, including bioprocessing, due to their unique functional properties and low reactivity.
- This restriction proposes a universal ban over time on the use of all fluoropolymers in all applications, without distinguishing between fluoropolymers and other PFAS substances.
- "Let's find solutions that better balance the environmental and health concerns with the needs of patients, consumers and the bioprocessing industry."
- We urge ECHA to reconsider its proposed restriction based on the available scientific data and risk assessments regarding PFAS substances, including fluoropolymers, used in bioprocessing.